Results 81 to 90 of about 546,603 (232)

Association of ABO blood group and secretor phenotype with severe COVID‐19 [PDF]

open access: yesTransfusion, 2020
Valenti, Luca   +6 more
openaire   +3 more sources

Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype.

open access: yesThe Journal of biological chemistry, 1995
Synthesis of soluble A, B, H, and Lewis b blood group antigens in humans is determined by the Secretor (Se) (FUT2) blood group locus. Genetic, biochemical, and molecular analyses indicate that this locus corresponds to an alpha(1,2)fucosyltransferase gene distinct from the genetically-linked H blood group alpha(1,2)fucosyltransferase locus.
R J, Kelly   +4 more
openaire   +2 more sources

Strong but not absolute correlation between the G428A FUT2 nonsense mutation and symptomatic NoV infection.

open access: yes, 2013
*SeSe and Sese428 vs.
Alberto Arnedo (372844)   +12 more
core   +1 more source

Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer

open access: yesMolecular Oncology, EarlyView.
Cancer cells' high translational demand creates opportunities to therapeutically target ribosome function. Ribosome stalling and collisions activate ZAKα and the ribotoxic stress response (RSR), which can trigger rapid, p53‐independent apoptosis in cancer.
Anastassiya Kim   +7 more
wiley   +1 more source

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani   +9 more
wiley   +1 more source

ABH Secretor Status Using Lewis blood type and Saliva Test

open access: yes, 1994
We studied the ABH secretor status using Lewis blood type and saliva test in 85 patients who underwent septoplasty or intranasal ethmoidectomy.
윤주헌, 이정권
core  

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

Detection of a rare subgroup of A phenotype while resolving ABO discrepancy

open access: yesAsian Journal of Transfusion Science, 2019
Weaker subgroups of ABO blood group system give rise to discrepancies between forward and reverse grouping and cause diagnostic difficulties in routine blood banking.
Revathy Nair   +3 more
doaj   +1 more source

Effect of secretor status on Prevotella abundance.

open access: yes, 2016
Effect of secretor status on Prevotella abundance.
Paula Smith-Brown (3127242)   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy